TEK and glioblastoma: In addition, the team that developed the Tie2-monocyte model for cancer therapy [26–28, 32], recently tested the effect of myeloid cells engineered for the inducible release of IFNα and Interleukin-12 (IL12) in glioblastoma (GBM) [33].